New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ProPhase Labs, Inc.
PRPH
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

11M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Mar 2025

11M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Mar 2025

0.34USD

Shape0.06 ( 21.96%)
sun-fogPre-market 0.37$arrow-left-down-0.01 (-1.48%)
Market Closed (as of Feb 13, 20:09 EDT)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

23565%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

95%

Quote Panel

Shape
Updated March 11, 2025
1W -8.84 % 1M 35.69 % 3M -43.78 % 1Y -84.14 %

Key Metrics

Shape
  • Market Cap

    11.37M


  • Shares Outstanding

    29.87M


  • Share in Float

    25.49M


  • Dividende

    0


  • Earning Date

    27 Mar 2025


  • Price Target

    0.3806


  • Average Volume

    9.88M


  • Beta

    -0.512


  • Range

    0.22-7.48


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.prophaselabs.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

PRPH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.08
vs 0.44

Q1.23

arrow
arrow

-96%

0.03
vs 0.68

Q2.23

arrow
arrow

N/A

-0.20
vs 0.4

Q3.23

arrow
arrow

N/A

-0.30
vs 0.06

Q4.23

arrow
arrow

N/A

-0.51
vs -0.08

Q1.24

arrow
arrow

N/A

-0.07
vs 0.03

Q2.24

arrow
arrow

N/A

-0.33
vs -0.20

Q3.24

arrow
arrow

N/A

-0.35
vs -0.30

Q4.24

arrow
arrow

N/A

-0.24
vs -0.51

Q1.25

arrow
arrow

N/A

-0.18
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-52%

21.8M  vs 45.2M

Q1.23

arrow
arrow

-59%

19.3M  vs 47.5M

Q2.23

arrow
arrow

-55%

13.2M  vs 29.1M

Q3.23

arrow
arrow

-65%

8.4M  vs 24.2M

Q4.23

arrow
arrow

-84%

3.5M  vs 21.8M

Q1.24

arrow
arrow

-81%

3.6M  vs 19.3M

Q2.24

arrow
arrow

-81%

2.5M  vs 13.2M

Q3.24

arrow
arrow

-62%

3.1M  vs 8.4M

Q4.24

arrow
arrow

+8%

3.8M  vs 3.5M

Q1.25

arrow
arrow

-33%

2.5M  vs 3.6M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-4%

-0.04
vs 0.01

Q1.23

arrow
arrow

+1%

0.01
vs -0.04

Q2.23

arrow
arrow

-6%

-0.06
vs 0.01

Q3.23

arrow
arrow

-9%

-0.09
vs -0.06

Q4.23

arrow
arrow

-18%

-0.18
vs -0.09

Q1.24

arrow
arrow

-14%

-0.14
vs -0.18

Q2.24

arrow
arrow

-14%

-0.14
vs -0.14

Q3.24

arrow
arrow

-17%

-0.17
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

41

41
vs 54

-24%

Q2.23

arrow
arrow

47

47
vs 41

15%

Q3.23

arrow
arrow

36

36
vs 47

-23%

Q4.23

arrow
arrow

27

27
vs 36

-25%

Q1.24

arrow
arrow

32

32
vs 27

19%

Q2.24

arrow
arrow

30

30
vs 32

-6%

Q3.24

arrow
arrow

25

25
vs 30

-17%

Q4.24

arrow
arrow

30

30
vs 25

20%

Earnings Growth

Latest News